An experimental study performed by Guo et al. [71] on NSCLC specimens demonstrated that increasing expression of ADAM10 promoted lung cancer cell migration and invasion via the activation of the transmembrane receptor Notch 1 signaling pathway. Here, ADAM10 is linked to non-small cell lung carcinoma.